Search Results for citation:"86 FR 10081"

Found 3 results

Search Results: citation:"86 FR 10081"

💰 Only
Oldest Newest
  • 2021-03190 — National Center for Advancing Translational Sciences; Notice of Closed Meeting
    Type:Notice
    Citation:86 FR 10081
    Reading Time:about a minute or two

    The National Center for Advancing Translational Sciences is holding a closed meeting on March 9, 2021, to evaluate grant applications. This meeting will be virtual and not open to the public because it will discuss confidential information, including trade secrets and personal data. The meeting, aimed at assessing applications for the CTSA Revision Award, will be managed by Dr. Rahat Khan, a Scientific Review Officer from the National Institutes of Health.

    Simple Explanation

    In March 2021, a group in charge of giving money for science projects will have a secret meeting online to talk about picking the best projects. They are keeping it private because they'll be discussing sensitive information like secrets and personal details.

  • 2021-03222 — Prospective Grant of an Exclusive Patent License: Autologous Therapy for the Treatment of Autoimmune Disease Using Chimeric Antigen Receptors Targeting CD19
    Type:Notice
    Citation:86 FR 10081
    Reading Time:about 4 minutes

    The National Cancer Institute, part of the National Institutes of Health, is considering granting an exclusive patent license to Kyverna Therapeutics for technology involving chimeric antigen receptors (CARs) that target the CD19 protein. This technology is aimed at creating a treatment for autoimmune diseases using a patient’s own altered T lymphocytes. The license could cover worldwide territories and would allow Kyverna to develop, produce, and market this therapy. Public comments or objections about the patent license need to be submitted by March 5, 2021.

    Simple Explanation

    The National Cancer Institute is thinking about letting a company called Kyverna Therapeutics use a special idea to help make sick immune systems better. They want people to say what they think about it soon, but only have about two weeks to do so.

  • 2021-03231 — Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-Funding Opportunity Announcement (FOA), RFA OH-21-003, Extension of the World Trade Center Health Registry (U50); Amended Notice of Meeting
    Type:Notice
    Citation:86 FR 10081
    Reading Time:less than a minute

    The Centers for Disease Control and Prevention (CDC) announced a notice regarding a meeting related to a funding opportunity for the World Trade Center Health Registry. This meeting is part of the CDC's efforts to handle issues involving disease, disability, and injury prevention. Marilyn Ridenour, Scientific Review Officer at the CDC, is the contact person for further information. Kalwant Smagh, a director at the CDC, has been given the authority to issue these types of announcements.

    Simple Explanation

    The CDC is having a meeting to talk about money they can give to help keep track of people’s health after the big building in New York City was knocked down. They haven’t told us what they will talk about at the meeting or how much it will cost.